HEMATOLOGIC CANCER

This study is testing a new support program for cancer survivors who struggle to afford or access healthy food. Researchers will compare 100 patients who receive help from a patient navigator to those getting standard care, to see if the program improves food security, diet quali…

This study is testing a new way to coordinate care for cancer patients who also have other ongoing health problems like diabetes or high blood pressure. It will involve 340 patients with breast, gastrointestinal, or blood cancers. The goal is to see if better teamwork between can…

This study is testing whether some multiple myeloma patients who are in a very deep, sustained remission can safely stop their long-term maintenance therapy. It will enroll about 70 patients who have been on therapy for at least two years and have no signs of cancer in very sensi…

This study is testing whether hypnosis can help reduce anxiety in people recently diagnosed with certain types of blood cancer (lymphoma). Researchers will measure anxiety levels in 50 patients before and after they receive 2-3 hypnosis sessions over 3 months. The goal is to see …

This study is testing whether simple, non-drug approaches can help reduce brain-related side effects (neurotoxicity) that sometimes occur after a powerful cancer treatment called CAR-T therapy. Researchers will enroll 100 adults with blood cancers and randomly assign them to eith…

This study aims to collect detailed genetic information and health records from 25,000 adults who have cancer or are at risk of developing it. Researchers will analyze this data to better understand how cancer develops and to identify potential targets for future treatments. The …

This study tests a support program designed to help Black, Latino, and older adult cancer patients overcome barriers to getting genetic testing. Genetic testing is often required to qualify for newer, targeted cancer treatments and clinical trials. The program includes a patient …

This study aims to better predict and detect dangerous side effects, like Cytokine Release Syndrome (CRS), in blood cancer patients receiving new immunotherapies. Researchers will monitor 100 patients using wireless sensors to track vital signs and blood tests to measure immune r…